Current Report Filing (8-k)
June 01 2020 - 04:36PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
December 31, 2019
Kewaunee Scientific Corporation
(Exact name of registrant as specified in its
charter)
|
|
|
|
|
Delaware |
|
0-5286 |
|
38-0715562 |
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
2700 West Front Street
Statesville, North Carolina
|
|
28677 |
(Address of principal executive
offices) |
|
(Zip Code) |
Registrant’s telephone number, including area
code: 704-873-7202
N/A
(Former name or former address, if changed since
last report.)
Securities registered pursuant to Section 12(b) of the
Act:
|
|
|
|
|
Title of each class
|
|
Trading Symbol(s)
|
|
Name of each exchange
on which registered
|
Common Stock, $2.50 par
value |
|
KEQU |
|
NASDAQ Global Market |
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
☐ |
Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
☐ |
Pre-commencement communications
pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))
|
☐ |
Pre-commencement communications
pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933
(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of
1934 (§240.12b-2 of this
chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange
Act. ☐
Item 5.02 |
Departure of Directors or Certain Officers;
Election of Directors; Appointment of Certain Officers;
Compensatory Arrangements of Certain Officers.
|
(b) Michael G. Rok, the former Vice
President of Manufacturing Operations of Kewaunee Scientific
Corporation (the “Company”), retired on December 31, 2019.
On June 1, 2020, the Company issued a press release announcing
the hiring of Douglas J. Batdorff as Vice President of
Manufacturing Operations. A copy of the press release is filed as
Exhibit 99.1 hereto and incorporated herein by reference.
Item 9.01 |
Financial Statements and Exhibits.
|
(d) Exhibits
Signature
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
(Registrant)
Kewaunee Scientific Corporation
|
|
|
Date: June 1, 2020 |
|
/s/ Donald T. Gardner III
|
|
|
Donald T. Gardner III |
|
|
Vice President, Finance and Chief Financial
Officer |